2019 preliminary results · over 850 systems sold into over 500 medical institutions • revenue...

15
2019 Preliminary Results Transforming ultrasound scanning through AI Year ended 31 December 2019 (unaudited)

Upload: others

Post on 30-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

2019 Preliminary Results

Transforming ultrasound scanning through AI

Year ended 31 December 2019 (unaudited)

Page 2: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

• Revenue up 11% to £5.9m

• Gross margin strong at 58%

• Close to divisional EBITDA breakeven

• North America revenue up 53% to £2.7m

• SonoSite co-marketing agreement signed

SIMULATION BASED TRAINING IN THE CLASSROOM AI BASED IMAGE ANALYSIS IN THE CLINIC

Providing a range of hi-fidelity simulators for educating and training ultrasound practitioners and improving patient care by raising scanning standards around the world

Developing a range of AI-based software for real-time guidance and image analysis during ultrasound scanning,

to improve the speed and standard of scanning worldwide

SIMULATION DIVISION CLINICAL AI DIVISION

• First OEM contract signed

• All milestones on target

• Second product at regulatory phase

and in commercial discussions

• Image database grown to 4m images

HIGHLIGHTS OF THE YEAR

Page 3: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

3

SIMULATION DIVISION

Training to the highest standards

Page 4: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

Over 850 systems sold into over 500 medical institutions

• Revenue steady at £2.6m• Important multiple sales to

Romanian universities• Encouraging sales in Iberia

ROW:

Simulation Division

North America:

• Revenue up 53% to £2.7m• Strong BodyWorks and HeartWorks

sales• SonoSite agreement signed• Support team expanded

UK:

• Revenue down 27% to £0.7m• Difficult purchasing market despite clinical demand• Q1 2020 showing encouraging early recovery

Page 5: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

Simulation division revenue growth since 2013

United Kingdom19%

North America32%

Rest of World49%

Geographic Revenue

2018

United Kingdom

11%

North America45%

Rest of World44% Geographic

Revenue2019

2013 2014 2015 2016 2017 2018 2019

H2 0.7 1.1 1.2 2.0 2.1 2.8 2.6

H1 0.6 0.7 1.1 1.3 2.1 2.5 3.3

-

1.0

2.0

3.0

4.0

5.0

6.0

7.0

Simulation Division Revenue

H1 H2

£5.3m

£4.2m

£3.3m

£2.3m

£1.8m

£1.3m

£5.9m

12%

44%

Page 6: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

BodyWorks for COVID-19

6

• Post year end launch

• New version of BodyWork’s PoCUS simulator

released for COVID-19

• Enables hands-on training for frontline

clinical staff to use lung ultrasound to

diagnose COVID-19 disease

• Free upgrade for all hospital users

• First systems in the UK and US live on 23

March 2020

Page 7: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

CLINICAL AI DIVISION

Speeding up scanning and reducing misdiagnosis

Page 8: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

• First long-term licensing agreement

• with one of the world’s leading ultrasound

manufacturers

• Integrating our AI image analysis

software

• onto a global range of ultrasound systems

• Generating high margin royalty

• Revenues expected from 2021

• Following regulatory approval

• More agreements expected to follow

First global AI licence signed

Page 9: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

9

Page 10: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

Proof of Concept

OEM agreement

OEM integration

First revenue expected

Product in development

Regulatory process

ProductAI

PLATFORM

Image analysis product 1

Image analysis product 4

H1 2021

H1 2022

2021

TBC

TBC

TBC

TBC

TBC

TBC

TBC

TBC

TBC

AI software platform A

Image analysis product 6

Image analysis product 9

Image analysis product 2

Image analysis product 5

Image analysis product 7

Image analysis product 3

AI software platform B

AI software platform C

AI software platform D

Image analysis product 4

Image analysis product 6

Image analysis product 9

Multi-platform, multi-licence strategy

10

Launch

Image analysis product 4

OEM version

Non OEM version

Page 11: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

COVID-19 Impact

• The recent spread of the COVID-19 virus is impacting all regions in which the Group

operates

• There is also considerable uncertainty over the likely duration of the disruption

• To counter any short term slow-down in global simulator sales, we have implemented

several cost-saving measures

• This will enable the Group’s EBITDA in FY2020 to remain in line with expectations

• The outlook for the medium and long term remains unchanged

• Group expects to have sufficient funds to continue its simulation and AI business activities

for 12 months

• When the revenues from its first AI software licence agreement are expected to come on

stream

11

Page 12: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

FINANCIALS2019 UNAUDITED PRELIMINARY RESULTS

Page 13: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

CONSOLIDATED INCOME STATEMENT

13

Page 14: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

14

Page 15: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market

CONSOLIDATED STATEMENT OF CASH FLOWS

15